INNOVEX INTERNATIONAL INC (INVX) Stock Fundamental Analysis

NYSE:INVX • US4576511079

28.58 USD
+1.41 (+5.19%)
Last: Feb 24, 2026, 03:23 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

Taking everything into account, INVX scores 7 out of 10 in our fundamental rating. INVX was compared to 61 industry peers in the Energy Equipment & Services industry. While INVX has a great health rating, its profitability is only average at the moment. INVX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes INVX very considerable for growth investing!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • INVX had positive earnings in the past year.
  • INVX had a positive operating cash flow in the past year.
  • In multiple years INVX reported negative net income over the last 5 years.
  • In multiple years INVX reported negative operating cash flow during the last 5 years.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • With an excellent Return On Assets value of 8.06%, INVX belongs to the best of the industry, outperforming 86.89% of the companies in the same industry.
  • INVX has a better Return On Equity (9.73%) than 70.49% of its industry peers.
  • INVX has a better Return On Invested Capital (8.34%) than 72.13% of its industry peers.
Industry RankSector Rank
ROA 8.06%
ROE 9.73%
ROIC 8.34%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • The Profit Margin of INVX (10.58%) is better than 86.89% of its industry peers.
  • In the last couple of years the Profit Margin of INVX has grown nicely.
  • INVX has a better Operating Margin (12.21%) than 65.57% of its industry peers.
  • INVX's Operating Margin has improved in the last couple of years.
  • The Gross Margin of INVX (32.35%) is better than 70.49% of its industry peers.
  • INVX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.21%
PM (TTM) 10.58%
GM 32.35%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), INVX is destroying value.
  • INVX has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, INVX has more shares outstanding
  • Compared to 1 year ago, INVX has a worse debt to assets ratio.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

  • INVX has an Altman-Z score of 7.14. This indicates that INVX is financially healthy and has little risk of bankruptcy at the moment.
  • INVX has a Altman-Z score of 7.14. This is amongst the best in the industry. INVX outperforms 98.36% of its industry peers.
  • INVX has a debt to FCF ratio of 0.19. This is a very positive value and a sign of high solvency as it would only need 0.19 years to pay back of all of its debts.
  • INVX's Debt to FCF ratio of 0.19 is amongst the best of the industry. INVX outperforms 93.44% of its industry peers.
  • A Debt/Equity ratio of 0.02 indicates that INVX is not too dependend on debt financing.
  • INVX's Debt to Equity ratio of 0.02 is amongst the best of the industry. INVX outperforms 88.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.19
Altman-Z 7.14
ROIC/WACC0.96
WACC8.72%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

  • INVX has a Current Ratio of 4.78. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.78, INVX belongs to the top of the industry, outperforming 95.08% of the companies in the same industry.
  • INVX has a Quick Ratio of 2.93. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 2.93, INVX belongs to the best of the industry, outperforming 93.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.78
Quick Ratio 2.93
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

9

3. Growth

3.1 Past

  • INVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 246.15%, which is quite impressive.
  • INVX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 123.23% yearly.
  • The Revenue has grown by 47.71% in the past year. This is a very strong growth!
  • Measured over the past years, INVX shows a quite strong growth in Revenue. The Revenue has been growing by 9.76% on average per year.
EPS 1Y (TTM)246.15%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%170.59%
Revenue 1Y (TTM)47.71%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%58.09%

3.2 Future

  • INVX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 66.90% yearly.
  • INVX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.31% yearly.
EPS Next Y446.5%
EPS Next 2Y160.71%
EPS Next 3Y95.77%
EPS Next 5Y66.9%
Revenue Next Year97.7%
Revenue Next 2Y43.21%
Revenue Next 3Y28.85%
Revenue Next 5Y22.31%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 30.08, which means the current valuation is very expensive for INVX.
  • INVX's Price/Earnings ratio is a bit cheaper when compared to the industry. INVX is cheaper than 60.66% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.64. INVX is around the same levels.
  • Based on the Price/Forward Earnings ratio of 17.52, the valuation of INVX can be described as rather expensive.
  • INVX's Price/Forward Earnings ratio is rather cheap when compared to the industry. INVX is cheaper than 83.61% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 27.75. INVX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 30.08
Fwd PE 17.52
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • INVX's Enterprise Value to EBITDA is on the same level as the industry average.
  • Based on the Price/Free Cash Flow ratio, INVX is valued cheaply inside the industry as 81.97% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.95
EV/EBITDA 9.98
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • INVX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • INVX has a very decent profitability rating, which may justify a higher PE ratio.
  • INVX's earnings are expected to grow with 95.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.07
PEG (5Y)0.24
EPS Next 2Y160.71%
EPS Next 3Y95.77%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • INVX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INNOVEX INTERNATIONAL INC

NYSE:INVX (2/24/2026, 3:23:31 PM)

28.58

+1.41 (+5.19%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-23
Earnings (Next)N/A
Inst Owners47.97%
Inst Owner Change3.05%
Ins Owners1.52%
Ins Owner Change-3.53%
Market Cap1.97B
Revenue(TTM)955.34M
Net Income(TTM)101.12M
Analysts77.78
Price Target25.5 (-10.78%)
Short Float %N/A
Short Ratio7.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.45
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-43.31%
Min EPS beat(2)-62.53%
Max EPS beat(2)-24.08%
EPS beat(4)1
Avg EPS beat(4)-15.03%
Min EPS beat(4)-62.53%
Max EPS beat(4)49.19%
EPS beat(8)1
Avg EPS beat(8)-142.72%
EPS beat(12)2
Avg EPS beat(12)-111.91%
EPS beat(16)3
Avg EPS beat(16)-84.71%
Revenue beat(2)1
Avg Revenue beat(2)2.01%
Min Revenue beat(2)-4.42%
Max Revenue beat(2)8.43%
Revenue beat(4)3
Avg Revenue beat(4)5.34%
Min Revenue beat(4)-4.42%
Max Revenue beat(4)10.21%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.29%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.07%
Valuation
Industry RankSector Rank
PE 30.08
Fwd PE 17.52
P/S 2.06
P/FCF 13.95
P/OCF 11.26
P/B 1.9
P/tB 2.39
EV/EBITDA 9.98
EPS(TTM)0.95
EY3.32%
EPS(NY)1.63
Fwd EY5.71%
FCF(TTM)2.05
FCFY7.17%
OCF(TTM)2.54
OCFY8.88%
SpS13.86
BVpS15.07
TBVpS11.94
PEG (NY)0.07
PEG (5Y)0.24
Graham Number17.95
Profitability
Industry RankSector Rank
ROA 8.06%
ROE 9.73%
ROCE 10.56%
ROIC 8.34%
ROICexc 9.79%
ROICexgc 12.7%
OM 12.21%
PM (TTM) 10.58%
GM 32.35%
FCFM 14.78%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y74.94%
ROICexc growth 3YN/A
ROICexc growth 5Y70.29%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.19
Debt/EBITDA 0.12
Cap/Depr 59.02%
Cap/Sales 3.54%
Interest Coverage 80.3
Cash Conversion 100.59%
Profit Quality 139.63%
Current Ratio 4.78
Quick Ratio 2.93
Altman-Z 7.14
F-Score7
WACC8.72%
ROIC/WACC0.96
Cap/Depr(3y)71.76%
Cap/Depr(5y)56.98%
Cap/Sales(3y)4.99%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)246.15%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%170.59%
EPS Next Y446.5%
EPS Next 2Y160.71%
EPS Next 3Y95.77%
EPS Next 5Y66.9%
Revenue 1Y (TTM)47.71%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%58.09%
Revenue Next Year97.7%
Revenue Next 2Y43.21%
Revenue Next 3Y28.85%
Revenue Next 5Y22.31%
EBIT growth 1Y95.65%
EBIT growth 3YN/A
EBIT growth 5Y80.9%
EBIT Next Year100.38%
EBIT Next 3Y37.48%
EBIT Next 5Y29.59%
FCF growth 1Y326.98%
FCF growth 3Y41.07%
FCF growth 5Y90.29%
OCF growth 1Y586.06%
OCF growth 3Y34.47%
OCF growth 5Y44.76%

INNOVEX INTERNATIONAL INC / INVX FAQ

Can you provide the ChartMill fundamental rating for INNOVEX INTERNATIONAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to INVX.


Can you provide the valuation status for INNOVEX INTERNATIONAL INC?

ChartMill assigns a valuation rating of 7 / 10 to INNOVEX INTERNATIONAL INC (INVX). This can be considered as Undervalued.


What is the profitability of INVX stock?

INNOVEX INTERNATIONAL INC (INVX) has a profitability rating of 6 / 10.


How financially healthy is INNOVEX INTERNATIONAL INC?

The financial health rating of INNOVEX INTERNATIONAL INC (INVX) is 8 / 10.


Can you provide the dividend sustainability for INVX stock?

The dividend rating of INNOVEX INTERNATIONAL INC (INVX) is 0 / 10 and the dividend payout ratio is 0%.